Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
960 GBX | +1.05% | -1.54% | +41.18% |
Mar. 21 | 4basebio updates markets on "key milestone" with client | AN |
Mar. 01 | Alpha Real Trust says in "robust" financial shape | AN |
Sales 2023 * | 500K 631K | Sales 2024 * | 2M 2.52M | Capitalization | 123M 155M |
---|---|---|---|---|---|
Net income 2023 * | -7M -8.84M | Net income 2024 * | -7M -8.84M | EV / Sales 2023 * | 231 x |
Net cash position 2023 * | 7.2M 9.09M | Net cash position 2024 * | 15.1M 19.06M | EV / Sales 2024 * | 53.9 x |
P/E ratio 2023 * |
-16
x | P/E ratio 2024 * |
-16
x | Employees | 78 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 15.02% |
1 day | +1.05% | ||
1 week | -1.54% | ||
Current month | +17.79% | ||
1 month | +21.52% | ||
3 months | +41.18% | ||
6 months | +72.20% | ||
Current year | +41.18% |
Managers | Title | Age | Since |
---|---|---|---|
Heikki Lanckriet
CEO | Chief Executive Officer | 47 | 20-12-21 |
David John Roth
DFI | Director of Finance/CFO | 56 | 20-12-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Fernández
BRD | Director/Board Member | 64 | - |
David John Roth
DFI | Director of Finance/CFO | 56 | 20-12-21 |
Director/Board Member | 53 | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 960 | +1.05% | 6,794 |
24-03-27 | 950 | 0.00% | 1,891 |
24-03-26 | 950 | -1.04% | 835 |
24-03-25 | 960 | -1.54% | 4,419 |
24-03-22 | 975 | 0.00% | 2,922 |
Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+41.18% | 155M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |